NCT06259357

Brief Summary

The purpose of this study is to determine the practicality of performing a future, large-scale study. The future study will look at the effect of mechanical ventilation in neurologically deceased (brain-dead) lung donors who are positioned to lay flat on their stomach (prone position), compared to donors who are positioned to lay flat on their back (supine position). The study will also look at the potential impact of prone positioning of the donor on transplant recipients of the study organs. The investigators are doing this study because the investigators want to increase the availability of donor lungs for lung transplant. Lung transplant is a life-saving treatment for individuals with lung disease, but there are not enough donated lungs to meet demand. Researchers are looking for better ways of preventing donated lungs from becoming unsuitable for transplant. Because of this, the goal of our study is to test whether prone positioning in neurologically deceased (brain-dead) lung donors can improve donor lung function and decrease complications, potentially increasing the number of donor lungs that can be used for transplant.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jan 2025Aug 2026

First Submitted

Initial submission to the registry

February 6, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

January 2, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

7 months

First QC Date

February 6, 2024

Last Update Submit

December 3, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • This pilot randomized controlled trial will assess the feasibility of conducting a future full randomized clinical trial, specifically, to determine whether donor accrual will be adequate (if we recruit 40 donors from 4 sites over 1 year)

    The number of donors enrolled into the trial over 1 year to be placed into either prone positioning or supine positioning prior to lung transplant

    90 days

  • To document adherence to the explicit prone positioning and mechanical ventilation protocol (if more than 80% of donors have no major protocol violations then considered adequate)

    Number of major protocol violations, specifically: 1. Time from donation consent to randomization \> 3 hours; 2. Time from randomization to initiation of study assigned protocol \> 3 hours; 3. Time spent in prone positioning \< 50% of the total time from study consent to study termination

    90 days

  • To document the number of those who cross over to the alternate strategy (if fewer than 10% of donors cross over to the alternate strategy, when not allowed by protocol then considered adequate)

    The percentage of donors who cross over to the alternate strategy, when not allowed by protocol

    90 days

Study Arms (2)

Protocolized protective mechanical ventilation in prone position

EXPERIMENTAL
Other: Protocolized protective mechanical ventilation in prone position

Protocolized protective mechanical ventilation in supine position

NO INTERVENTION

Interventions

Prone Position: Study subjects randomized to the intervention group will be placed and maintained in prone position for at least 16 hours/day until the time of organ procurement or decline (typically 24-48 hours after donation consent) or the time that the lungs are declined for transplant.

Protocolized protective mechanical ventilation in prone position

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Neurological determination of death at time of study entry
  • Consent to organ donation
  • Eligible for organ donation as confirmed by Trillium Gift of Life Network Coordinator

You may not qualify if:

  • Open chest or abdominal wounds on the ventral body surface
  • Absolute contraindication to lung transplantation on initial eligibility screening:
  • Infection i. Positive HIV, HbsAg, Human T-lymphotropic virus-I/II test results ii. Positive West Nile Virus (WNV PCR) test results iii. Rabies diagnosis or within the last 6 months bitten by an animal proven to have rabies iv. Active endocarditis v. Active encephalitis or meningitis of unknown etiology vi. Active disseminated tuberculosis vii. Viral hemorrhagic fever including Ebola or known exposure to person with Ebola viii. COVID-19 presumptive or confirmed positive in the last 14 days
  • Malignancy i. Donors with active cancer (donors receiving chemotherapy or radiation therapy or palliative cancer care within the last 5 years); excluding skin and primary brain tumors and prostate cancers.
  • ii. Donors with a history of the following malignancies:
  • Lung Cancer
  • Choriocarcinoma
  • Breast Cancer
  • Colon Cancer within the last 10 years iii. Donors with active or past history of melanoma o Clinician decision that prone position is contraindicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto General Hospital

Toronto, Ontario, M5G 2N2, Canada

Location

MeSH Terms

Interventions

Prone Position

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, Critical Care Medicine Department, Toronto General Hospital

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 14, 2024

Study Start

January 2, 2025

Primary Completion

August 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

December 4, 2024

Record last verified: 2024-12

Locations